Oppenheimer & Co’s EyePoint Inc EYPT Stock Holding History

Oppenheimer & Co’s Portfolio EYPT Stock Details EYPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,806	Closed	-$197K	–	1725
2025 Q4	$197K	Buy	+10,806	New	+$153K	﹤0.01%	1435

Other funds holding EYPT

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Oppenheimer & Co's EYPT Position: Q1 2026 in Review

Oppenheimer & Co sold out of EyePoint Inc (EYPT) in Q1 2026, closing a stake of 10,806 shares — an estimated $197K sold.

Oppenheimer & Co first reported a position in EYPT in Q4 2025 and held it in 1 quarter. The position peaked at $197K in Q4 2025. 188 funds tracked by Wall St. Rank hold EYPT as of Q1 2026.

Oppenheimer & Co reported no remaining EyePoint Inc position as of Q1 2026 after selling out during the quarter.
Oppenheimer & Co sold 10,806 EyePoint Inc shares in Q1 2026, an estimated $197K.
Oppenheimer & Co first reported a position in EyePoint Inc in Q4 2025 and held it in 1 quarter.
Oppenheimer & Co's EyePoint Inc position peaked at $197K in Q4 2025.
188 funds tracked by Wall St. Rank held EyePoint Inc as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.